KRAS G12C inhibitor 39 is a selective inhibitor targeting the KRAS G12C mutation, which is frequently associated with various cancers. This compound demonstrates significant anti-tumor activity by interfering with KRAS signaling pathways, making it a valuable tool for research into KRAS G12C-mediated oncogenesis. Its application extends to studies aimed at understanding the efficacy of targeted therapies in KRAS-driven malignancies.
KRAS G12C inhibitor 39 is a selective inhibitor targeting the KRAS G12C mutation, which is frequently associated with various cancers. This compound demonstrates significant anti-tumor activity by interfering with KRAS signaling pathways, making it a valuable tool for research into KRAS G12C-mediated oncogenesis. Its application extends to studies aimed at understanding the efficacy of targeted therapies in KRAS-driven malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
